Omambac, Guillermo H.

HRN: 07-73-35  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/19/2022
CLINDAMYCIN 150MG/ML, 4ML (AMP)
12/19/2022
12/27/2022
IV
600mg
Q8hrs
Boil
Waiting Final Action 
12/19/2022
MUPIROCIN 2%, 15G (TUBE)
12/19/2022
12/27/2022
TOPICAL
2%
BID
Infected Wound
Waiting Final Action 
12/22/2022
SILVER SULFADIAZINE 1%, 25G CREAM (TUBE)
12/22/2022
12/29/2022
TOPICAL
1%
BID
Carbuncle
Waiting Final Action 
12/23/2022
CLINDAMYCIN 300MG (CAP)
12/23/2022
12/25/2022
PO
1 Cap
Q6H
Gluteal Abscess
Waiting Final Action 
12/26/2022
CLINDAMYCIN 150MG/ML, 4ML (AMP)
12/26/2022
01/02/2023
IV
600 Mg
Q6H
Soft Tissue Infection
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: